Apellis Pharmaceuticals, Inc. (APLS)

21.60 -0.53 (-2.39%) USD  |  NASDAQ  |  Feb 25, 12:04
More

Apellis Pharmaceuticals Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade